Šalis: Pietų Afrika
kalba: anglų
Šaltinis: South African Health Products Regulatory Authority (SAHPRA)
Janssen Pharmaceutica (Pty) Ltd
See ingredients
TABLET
EACH TABLET CONTAINS PARACETAMOL 325,0 mg TRAMADOL HYDROCHLORIDE 37,5 mg
Registered
2014-03-08
Applicant: JANSSEN PHARMACEUTICA (PTY) LTD Product Proprietary Name: ULTRACET® (44/2.9/0931) Dosage form and strength: 37,5 mg tramadol hydrochloride and 325 mg paracetamol per tablet ___________________________________________________________________________________ Page 1 of 16 PATIENT INFORMATION LEAFLET . _ _ _ _ _ _ ULTRACET Film coated tablets Each tablet contains 37,5 mg tramadol hydrochloride and 325 mg paracetamol. _ _ READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING ULTRACET • Keep this leaflet. You may need to read it again. • If you have further questions, please ask your doctor, pharmacist, nurse or other health care provider. • ULTRACET has been prescribed for you personally and you should not share your medicine with other people. It may harm them, even if their symptoms are the same as yours. WHAT IS IN THIS LEAFLET 1. What ULTRACET is and what it is used for 2. What you need to know before you take ULTRACET 3. How to use ULTRACET 4. Possible side effects 5. How to store ULTRACET 6. Contents of the pack and other information SCHEDULING STATUS Schedule 5 Applicant: JANSSEN PHARMACEUTICA (PTY) LTD Product Proprietary Name: ULTRACET® (44/2.9/0931) Dosage form and strength: 37,5 mg tramadol hydrochloride and 325 mg paracetamol per tablet ___________________________________________________________________________________ Page 2 of 16 1. WHAT ULTRACET IS AND WHAT IT IS USED FOR_ _ Tramadol and paracetamol are the active substances in ULTRACET. They are painkillers that act on the brain and spinal cord to control pain. ULTRACET is used for the management of moderate to moderately severe pain in adults. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ULTRACET DO NOT TAKE ULTRACET IF: • if you are hypersensitive (allergic) to tramadol or paracetamol or to any other opioid or any of the other ingredients of ULTRACET (listed in section 6); • if you take other medicines containing paracetamol or tramadol; • if you have a moderate to severe liver disease; • if you are taking alcohol; • if Perskaitykite visą dokumentą
_JANSSEN PHARMACEUTICA (PTY) LTD. _ _ULTRACET® (_44/2.9/0931_) _ _37,5 MG TRAMADOL HYDROCHLORIDE AND 325 MG PARACETAMOL PER TABLET _ _PROFESSIONAL INFORMATION (PI) _ _ _ _ _ _PAGE 1 OF 26 _ PROFESSIONAL INFORMATION 1 NAME OF THE MEDICINE ULTRACET Film coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 37,5 mg tramadol hydrochloride and 325 mg paracetamol. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet Light yellow, film-coated capsule-shaped tablet engraved “J-C” on one side and “T/P” on the other. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS ULTRACET is indicated for the management of moderate to moderately-severe pain in adults. ULTRACET is not recommended for minor pain that may be treated adequately through lesser means. SCHEDULING STATUS Schedule 5 _JANSSEN PHARMACEUTICA (PTY) LTD. _ _ULTRACET® (_44/2.9/0931_) _ _37,5 MG TRAMADOL HYDROCHLORIDE AND 325 MG PARACETAMOL PER TABLET _ _PROFESSIONAL INFORMATION (PI) _ _ _ _ _ _PAGE 2 OF 26 _ 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY To be used in adults and children over 16 years of age. DO NOT EXCEED THE RECOMMENDED DOSE. For the management of pain, the recommended maximum single dose of ULTRACET is 1 or 2 tablets every 4 to 6 hours as needed for pain relief up to a maximum of 8 tablets per day. The lowest effective dose should be used for the shortest period of time. A titration period of several days with gradual dose increases at the initiation of ULTRACET therapy may be beneficial for some patients. Clinical studies with tramadol in patients with moderate to moderately severe chronic pain indicate that the tolerability of tramadol can be improved by starting tramadol at a low dose with gradual upward dose titration to reach doses that provide sufficient pain relief. SPECIAL POPULATIONS Children below 16 years of age The use of ULTRACET is contraindicated in children below 12 years of age (see section 4.3, Contraindications). The safety and effectiveness of ULTRACET Perskaitykite visą dokumentą